Tokyo, June 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062005) titled 'A Cross-Sectional Study Assessing the Prevalence of Islet-Related Autoantibodies in Japanese Individuals with Prediabetes Using Biobank Serum Samples' on June 26.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Sanofi K.K.
Condition:
Condition - Individuals who met the criteria of prediabetes at health check-up
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To identify individuals within the Japanese population with pre- diabetes, who are in the early stages of type 1 diabetes (T1D), and estimating their proportion.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - 50
years-old
>
Gender - Male and Female
Key inclusion criteria - Individuals who are registered in the St.Luke's International Hospital Biobank, meet the diagnostic criteria for prediabetes in the health check-up at St. Luke's International Hospital, and have stored serum samples available for use.
Individuals who are younger than 50 years of age at the time of registration.
Individuals who have following information recorded at the time of registration: age, sex, blood glucose level, HbA1c level, height, weight, Complete Blood Count (WBC, RBC, HGB, HCT, MCV, MCH, MCHC, PLT), self-reported history of pharmacological treatment.
Key exclusion criteria - Individuals who are receiving pharmacological treatment for diabetes at the time of registration.
Target Size - 1600
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 05 Month 28 Day
Anticipated trial start date - 2026 Year 06 Month 01 Day
Last follow-up date - 2027 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070921
Disclaimer: Curated by HT Syndication.
